Fluoxetine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00472 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 49 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | schizoid personality disorder | KG + DL |
| 2 | histrionic personality disorder (disease) | KG + DL |
| 3 | schizotypal personality disorder | KG + DL |
| 4 | paranoid personality disorder | KG + DL |
| 5 | benign paroxysmal torticollis of infancy | KG + DL |
| 6 | agoraphobia | KG + DL |
| 7 | manic bipolar affective disorder | KG + DL |
| 8 | phobic disorder | KG + DL |
| 9 | Ohdo syndrome and variants | KG + DL |
| 10 | melancholia | KG + DL |
| 11 | neurotic depression | KG + DL |
| 12 | blepharophimosis - intellectual disability syndrome, Ohdo type | KG + DL |
| 13 | dependent personality disorder | KG + DL |
| 14 | narcissistic personality disorder | KG + DL |
| 15 | Keppen-Lubinsky syndrome | KG + DL |
| 16 | mixed anxiety and depressive disorder | KG + DL |
| 17 | ligneous conjunctivitis | KG + DL |
| 18 | avoidant personality disorder | KG + DL |
| 19 | post-traumatic stress disorder | KG + DL |
| 20 | congenital isolated adrenocorticotropic hormone deficiency (disease) | KG + DL |
| 21 | autosomal dominant slowed nerve conduction velocity | KG + DL |
| 22 | myofascial pain syndrome | KG + DL |
| 23 | vitamin B12-responsive methylmalonic acidemia | KG + DL |
| 24 | childhood apraxia of speech | KG + DL |
| 25 | surfactant metabolism dysfunction, pulmonary | KG + DL |
| 26 | trigeminal nerve neoplasm | KG + DL |
| 27 | Malan overgrowth syndrome | KG + DL |
| 28 | attention deficit-hyperactivity disorder | KG + DL |
| 29 | distal 17p13.3 microdeletion syndrome | KG + DL |
| 30 | chondromyxoid fibroma | KG + DL |
| 31 | chromosome 15q26-qter deletion syndrome | KG + DL |
| 32 | asperger syndrome, susceptibility to | KG + DL |
| 33 | trichotillomania | KG + DL |
| 34 | autism spectrum disorder | KG + DL |
| 35 | gaze palsy, familial horizontal, with progressive scoliosis | KG + DL |
| 36 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 37 | autism susceptibility 1 | KG + DL |
| 38 | chromosome 2P16.3 deletion syndrome | KG + DL |
| 39 | familial hypertryptophanemia | KG + DL |
| 40 | Tourette syndrome | KG + DL |
| 41 | faciodigitogenital syndrome | KG + DL |
| 42 | Pitt-Hopkins-like syndrome 2 | KG + DL |
| 43 | specific developmental disorder | KG + DL |
| 44 | hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | KG + DL |
| 45 | Phelan-McDermid syndrome | KG + DL |
| 46 | amelocerebrohypohidrotic syndrome | KG + DL |
| 47 | Asperger syndrome | KG + DL |
| 48 | schizophrenia | KG + DL |
| 49 | visual epilepsy | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.